Albert Beraldo
Vermogen: 242 031 $ op 30-06-2026
Vermogen: 242 031 $ op 30-06-2026
Albert George Beraldo was the founder of Alveda Pharmaceuticals, Inc., founded in 2006, where the titles held included President, Chief Executive Officer & Director from 2006 to 2015.
Current jobs include Chairman at Global Transplant Solutions, Inc. since 2018; Director at Medicenna Therapeutics, Inc.; Lead Independent Non-Executive Director at Medicenna Therapeutics Corp.
since 2016; and President at Idoman Ltd. since 2008.
Former jobs include President & Chief Executive Officer at Telesta Therapeutics, Inc.; President & Chief Executive Officer at Bioniche Pharma Group Ltd. from 2005 to 2006; Independent Non-Executive Director at Telesta Therapeutics, Inc. from 2012 to 2014; Director at Helix BioPharma Corp.
from 2016 to 2017; Independent Director at Pure Global Cannabis, Inc. from 2018 to 2020; and Controller at Vetrepharm Canada, Inc. Education includes undergraduate studies at the University of Windsor.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 28-05-2026 | 880.113 ( 0,95% ) | 242 031 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Directeur/Bestuurslid | 22-11-2016 |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for the treatment of central nervous system and urological cancers | Directeur/Bestuurslid | - |
Idoman Ltd. | President | 01-07-2008 |
Global Transplant Solutions, Inc.
Global Transplant Solutions, Inc. Medical/Nursing ServicesHealth Services Provides human organ preservation fluid solutions | Voorzitter | 01-07-2018 |
| Bedrijven | Functie | Einde |
|---|---|---|
| PURE GLOBAL CANNABIS INC. | Directeur/Bestuurslid | 01-05-2020 |
| HELIX BIOPHARMA CORP. | Directeur/Bestuurslid | 14-07-2017 |
Alveda Pharmaceuticals, Inc.
Alveda Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Sells and distributes pharmaceuticals and medical devices | Oprichter | 01-11-2015 |
| TELESTA THERAPEUTICS INC | Directeur/Bestuurslid | 01-02-2014 |
Bioniche Pharma Group Ltd.
Bioniche Pharma Group Ltd. Medical SpecialtiesHealth Technology Manufactures sterile injectable and other related pharmaceutical products | President | 01-01-2006 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 11 |
|---|---|
Telesta Therapeutics, Inc.
Telesta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Researches and develops pharmaceutical products for the human and veterinary markets | Health Technology |
Helix BioPharma Corp.
Helix BioPharma Corp. Pharmaceuticals: MajorHealth Technology Develops drugs for the prevention and treatment of cancer | Health Technology |
University of Windsor
University of Windsor Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioniche Pharma Group Ltd.
Bioniche Pharma Group Ltd. Medical SpecialtiesHealth Technology Manufactures sterile injectable and other related pharmaceutical products | Health Technology |
Alveda Pharmaceuticals, Inc.
Alveda Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Sells and distributes pharmaceuticals and medical devices | Retail Trade |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for the treatment of central nervous system and urological cancers | Health Technology |
Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Idoman Ltd. | |
Pure Global Cannabis, Inc.
Pure Global Cannabis, Inc. Pharmaceuticals: OtherHealth Technology Produces and distributes medical cannabis products | Health Technology |
Vetrepharm Canada, Inc. | |
Global Transplant Solutions, Inc.
Global Transplant Solutions, Inc. Medical/Nursing ServicesHealth Services Provides human organ preservation fluid solutions | Health Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau